Literature DB >> 22993357

Stereotactic body radiation therapy for stage I non-small cell lung cancer patients with chronic respiratory insufficiency requiring domiciliary oxygen therapy.

Tadamasa Yoshitake1, Katsumasa Nakamura, Yoshiyuki Shioyama, Tomonari Sasaki, Saiji Ohga, Takeshi Nonoshita, Kotaro Terashima, Kaori Asai, Keiji Matsumoto, Hiroshi Honda.   

Abstract

BACKGROUND: The efficacy of stereotactic body radiation therapy (SBRT) for patients treated with domiciliary oxygen therapy is not well-known. PATIENTS AND METHODS: We collected the clinical records of 15 patients with chronic respiratory insufficiency requiring domiciliary oxygen therapy at 1-3 l/min who were treated with SBRT for stage I non-small cell lung cancer. All patients were fixed with a thermoplastic body cast system. SBRT was given in 7-8 fields with an isocenter dose of 40-60 Gy in 4-10 fractions (median, 48 Gy in 4 fractions).
RESULTS: The overall 2-year and 5-year survival rates for all patients were 67.4% and 34.7%, while the disease-specific 2-year and 5-year survival rates were 90.0% and 72.0%, respectively. Pulmonary adverse effects were mild in the majority of the patients, although two patients had grade 2 radiation pneumonitis. The oxygen flow required increased slightly at follow-up periods greater than one year, but was still at an acceptable level.
CONCLUSION: SBRT was feasible for patients requiring domiciliary oxygen therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22993357

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Misjudgement of gefitinib efficacy in patients with central non-small-cell lung cancer due to obstructive atelectasis caused by stereotactic radiotherapy.

Authors:  Xueqin Yang; Yanli Xiong; Huan Huang; Bo Peng; Zejun Zhou; Mingfang Xu; Yi Yang; Dong Wang
Journal:  Mol Clin Oncol       Date:  2014-04-30

2.  Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy.

Authors:  Yu Hara; Atsuya Takeda; Takahisa Eriguchi; Naoko Sanuki; Yousuke Aoki; Shuichi Nishimura; Tatsuji Enomoto; Masaharu Shinkai; Akihiko Kawana; Takeshi Kaneko
Journal:  J Radiat Res       Date:  2015-10-20       Impact factor: 2.724

Review 3.  Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy?

Authors:  Nam P Nguyen; Juan Godinez; Wei Shen; Vincent Vinh-Hung; Helena Gorobets; Juliette Thariat; Fred Ampil; Jacqueline Vock; Ulf Karlsson; Alexander Chi
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.